Trends in Pricing and Out-of-Pocket Spending on Entecavir Among Commercially Insured Patients, 2014-2018.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35061044.
- Also identified by DOI 10.1001/jamanetworkopen.2021.44521 and PMC identifier 8783269.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study of health claims from patients with private insurance examines trends in the cost of entecavir prescribed for chronic hepatitis B treatment.
Medical subject headings
- Antiviral Agents
- Fees and Charges
- Financing, Personal
- Guanine
- Health Expenditures